Lessons from the long-term DES data: how they can inform today's practice

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: H. Abdel-Hadi, P. Smits

Summary

This session reviews long-term clinical data on drug-eluting stents (DES) and bioresorbable scaffolds (BRS), offering valuable insights to inform current interventional cardiology practice. It covers seven-year outcomes of magnesium scaffolds in ACS, five-year results of sirolimus-eluting iron BRS, and extensive post-market studies of various thin-strut and polymer-free stents, highlighting advances in scaffold technology and stent performance in complex coronary lesions.

Presentations available when logged in:

  • Seven-year outcomes of a magnesium scaffold in ACS a step to next generation
  • First-in-man evaluation of a sirolimus-eluting iron BRS: five-year results
  • Post-market study of the FANTOM BRS: long-term clinical outcomes
  • BIOMAG-I: four-year clinical outcomes of the resorbable magnesium scaffold-DREAMS 3G
  • Three-year clinical outcomes of ultra-thin stent in complex coronary lesions
  • Clinical outcomes of 4,000 patients treated with thin-strut CoCr polymer-free biolimus-coated stent